BioSpace News Archive

The first-in-human, phase 1 T cell trial for patients who have human papillomavirus (HPV)-associated cancers that have relapsed, or are resistant to treatment, is now open at City of Hope

One year ago, Swisslog Healthcare, a leader in medication management and transport automation products and solutions, held a ribbon-cutting ceremony on the grounds of a new 80,140 square foot facility in Westminster.

Med-X, Inc. -- On August 12, 2019, the Securities Exchange Commission (SEC) qualified Med-X, Inc. (Med-X) to begin the company’s second Regulation A+ Equity Crowdfunding Offering

The Medical Science Liaison Society (MSL Society), the only 501(c)(3) non-profit organization exclusively dedicated to advancing the global medical science liaison (MSL) profession, has announced the finalists for the 2019 MSL of the Year Awards.

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader using its CytoSorb® blood purification technology to treat deadly inflammation in critically-ill and cardiac surgery patients around the world, announced that CytoSorb has received renewal of its European Union CE Mark through May 2024 and ISO 13485:2016 Full Quality Assurance System certification of its manufacturing facility through September 2022.

Reforest The Tropics (RTT), a 501(c)(3) non-profit organization based in Mystic, Connecticut and New England Biolabs, Inc. (NEB®), a global leader in the production of reagents for the life science industry, announce that they have entered into an agreement to plant 100 hectares (247 acres) of new tropical forest in Costa Rica

Breaking Benjamin showcased in first St. Jude Inspire series

Intiva Health’s provider credential platform, Ready Doc™, now offers credential packaging, a new feature that enables facilities and providers to add professional documents to a secure, time-stamped digital folder that can be shared between licensed medical practitioners and healthcare facilities.

The MCTO does not affect the ability of investors who are not insiders to trade in the securities of the Company.